Immunology
Conference Coverage
Busting eczema treatment myths: applying the evidence
News
FDA approves mepolizumab for use in combination with other asthma drugs
Nucala (mepolizumab) has been approved for use with other asthma medicines as maintenance therapy for patients aged 12 years and older with a...
Conference Coverage
EADV: Another promising topical for atopic dermatitis
Key clinical point: The pipeline for nonsteroidal topical therapies for pediatric and adult atopic dermatitis shows great promise. Major finding:...
Commentary
No flu vaccine for patients with egg allergy?
Conference Coverage
EADV: Novel topical crisaborole shines in atopic dermatitis
Crisaborole topical ointment 2% b.i.d. appeared to be a safe and effective treatment for mild to moderate atopic dermatitis in children and adults...
News
Peripartum probiotics linked to lower atopic dermatitis risk in offspring
Peripartum consumption of probiotic milk was associated with a decline in the incidence of atopic dermatitis in offspring.
News
AAP: Give peanut products to high-risk infants to cut allergy risk
Medical groups advise early peanut introduction in those with eczema with or without egg allergy.
News
New HPV vaccine safe with meningitis, Tdap vaccines
Key clinical point: The new 9-valent HPV vaccine can be given with other standard vaccines in one visit. Major finding: No difference in safety or...
Conference Coverage
WCD: Pramocaine is a common contact sensitizer
Pramocaine, a topical anesthetic widely used in OTC anti-itch products, turns out to be a common cause of contact sensitization.
News
Severe anaphylaxis in children predicts biphasic reactions
Children who present with a severe anaphylactic reaction are two to three times more likely to develop a second delayed, or late-phase, reaction...
Conference Coverage
WCD: Topical tofacitinib hits marks in atopic dermatitis
Topical tofacitinib, a Janus kinase inhibitor, may provide a novel safe and effective therapy for atopic dermatitis.